Pharsight

Drugs that contain Telavancin Hydrochloride

1. Vibativ patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6635618 CUMBERLAND PHARMS Glycopeptide phosphonate derivatives
Sep, 2023

(6 months ago)

US7531623 CUMBERLAND PHARMS Hydrochloride salts of a glycopeptide phosphonate derivative
Jan, 2027

(2 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6858584 CUMBERLAND PHARMS Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
Aug, 2022

(1 year, 7 months ago)

Market Authorisation Date: 11 September, 2009

Treatment: Method for treating bacterial infection

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

VIBATIV family patents

Family Patents